Featured Site

Online Business - while you surf!

Everybody needs a means through which they can make a living. This is because you have basic needs that you need to cater for and also other luxuries that you may want to have. There are limited job opportunities in the market nowadays and therefore you need alternatives. One of the ways you can do this is through starting up your own business....

Thursday, September 24, 2009

AIDS breakthrough as vaccine cuts infections for first time


BANGKOK (AFP) - – An experimental AIDS vaccine has for the first time cut the risk of infection in humans in what scientists Thursday called a "breakthrough" in the quarter-century fight against the epidemic.

The vaccine reduced the chance of being infected by a third, researchers announced after the world's largest trial of 16,000 volunteers, carried out by the US Army and Thailand's Ministry of Public Health.

The surprising result comes after years of fruitless attempts by the medical world to find an HIV vaccine, including one trial jab that apparently boosted infection rates.

"It is the first demonstration that a vaccine against HIV can protect against infection," Colonel Jerome Kim of the US military HIV research programme told a news conference in Bangkok via videolink.

"This is a very important scientific advance and gives us hope that a globally effective vaccine may be possible in the future," he said.

Thai Public Health Minister Witthaya Kaewparadai said the "outcome of this study is a scientific breakthrough."

The vaccine was a combination of two older drugs that had not reduced infection on their own and the researchers said they were now studying why the two apparently worked together.

The study combined the canarypox vaccine ALVAC, manufactured by Sanofi-Aventis of France, and AIDSVAX, originally made by VaxGen Inc and now licensed to the non-profit Global Solutions for Infectious Diseases.

Researchers said the latest vaccine showed a 31.2 percent efficacy in reducing the risk of HIV infection.

"The outcome represents a breakthrough in HIV vaccine development because for the first time ever there is evidence that HIV vaccine has preventative efficacy," said the research team in a statement.

The vaccine was tested on volunteers -- all HIV negative men and women aged from 18 to 30 -- at average risk of infection in two Thai provinces near Bangkok starting in October 2003.

Half received the vaccine and the rest were given a placebo. Out of the placebo recipients 74 of 8,198 became infected compared with 51 of 8,197 who got the vaccine.

The World Health Organization and the Joint UN Programme on HIV/AIDS congratulated the researchers for the "encouraging" results.

"The study results, representing a significant scientific advance, are the first demonstration that a vaccine can prevent HIV infection in a general adult population and are of great importance," they said in a statement. Experts' reactions

The UN said it may not be possible to get licensing permission for the drug at the moment based on the results, and that further studies were needed to determine if the vaccine has the same effect in other parts of the world.

AIDS first came to public notice in 1981 and has since killed at least 25 million people worldwide, and 33 million others are living with AIDS or the HIV virus.

Swift progress in identifying the virus that caused AIDS unleashed early optimism that a vaccine would quickly emerge. HIV destroys immune cells and exposes the body to opportunistic disease.

But out of the 50 candidates that have been evaluated among humans, only two vaccines have made it through all three phases of trials, and both were flops. About 30 vaccines remain in the pipeline.

Scientists were in 2007 forced to abandon two advanced clinical trials of a vaccine by pharmaceutical company Merck after it appeared to actually heighten the risk of AIDS infection.

Sanofi Pasteur, the vaccines division of Sanofi-Aventis, said the results of the latest test, although "modest", were the first concrete demonstration that a vaccine "could one day become a reality."

The Global HIV Vaccine Enterprise, an alliance of researchers, policymakers, donors and advocates that includes the Bill and Melinda Gates Foundation, said it was a "historic day in the 26-year quest to develop an AIDS vaccine."

The International AIDS Vaccine Initiative (IAVI), an organisation that promotes the search for a vaccine, said the trial results were "very exciting and a significant scientific achievement."

The head of the US agency tasked with controlling the spread of infectious disease said it was an important breakthrough.

"These new findings represent an important step forward in HIV vaccine research," said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, which provided major funding and logistical support for the study.

But a top AIDS scientist, France's Jean-Francois Delfraissy, warned that the results were "good news but the effect remains modest".

(SOURCE:)
Yahoo! News

--

BARBIE goes to Hollywood!

Barbie is set to make her debut on the big screen in a family movie based on the iconic toy doll, entertainment industry press reported Thursday.

The 50-year-old figurine fashionista, reputedly the biggest selling toy of all time, will be brought to life by Universal Pictures following a deal between the studio and manufacturer Mattel, Variety reported.

"Barbie is the most famous doll in history, a unique cultural icon in the world of brands," Universal Pictures chairman Marc Shmuger said.

"So many representations of Barbie frequent pop culture. We're grateful to Mattel for entrusting us with this extraordinary opportunity."

There was no word on who might play Barbie or love interest Ken, but producer Laurence Mark said her varied career -- 120 jobs ranging from astronaut to aspiring politician -- offered myriad storylines.

"Barbie may be the most popular girl in the world, and has always been a wonderfully aspirational figure, so we must do her proud," Mark told Variety.

History:

Barbie is a fashion doll manufactured by the American toy-company Mattel, Inc. and launched in March 1959. American businesswoman Ruth Handler (1916-2002) is credited with the creation of the doll using a German doll called Bild Lilli as her inspiration.

Barbie has been an important part of the toy fashion doll market for fifty years, and has been the subject of numerous controversies and lawsuits, often involving parody of the doll and her lifestyle. In recent years, Barbie has faced increasing competition from the Bratz range of dolls.


Ruth Handler watched her daughter Barbara at play with paper dolls, and noticed that she often enjoyed giving them adult roles. At the time, most children's toy dolls were representations of infants. Realizing that there could be a gap in the market, Handler suggested the idea of an adult-bodied doll to her husband Elliot, a co-founder of the Mattel toy company. He was unenthusiastic about the idea, as were Mattel's directors.

During a trip to Europe in 1956 with her children Barbara and Kenneth, Ruth Handler came across German toy doll called Bild Lilli. The adult-figured doll was exactly what Handler had in mind, so she purchased three of them. She gave one to her daughter and took the others back to Mattel. The Lilli doll was based on a popular character appearing in a comic strip drawn by Reinhard Beuthin for the newspaper Die Bild-Zeitung. Lilli was a working girl who knew what she wanted and was not above using men to get it. The Lilli doll was first sold in Germany in 1955, and although it was initially sold to babies, it became popular with adults who enjoyed dressing her up in outfits that were available separately.

Upon her return to the United States, Handler reworked the design of the doll (with help from engineer Jack Ryan) and the doll was given a new name, Barbie, after Handler's daughter Barbara. The doll made its debut at the American International Toy Fair in New York on March 9, 1959. This date is also used as Barbie's official birthday.

Mattel acquired the rights to the Bild Lilli doll in 1964 and production of Lilli was stopped. The first Barbie doll wore a black and white zebra striped swimsuit and signature topknot ponytail, and was available as either a blonde or brunette. The doll was marketed as a "Teen-age Fashion Model," with her clothes created by Mattel fashion designer Charlotte Johnson. The first Barbie dolls were manufactured in Japan, with their clothes hand-stitched by Japanese homeworkers. Around 350,000 Barbie dolls were sold during the first year of production.

Ruth Handler believed that it was important for Barbie to have an adult appearance, and early market research showed that some parents were unhappy about the doll's chest, which had distinct breasts. Barbie's appearance has been changed many times, most notably in 1971 when the doll's eyes were adjusted to look forwards rather than having the demure sideways glance of the original model.

Barbie was one of the first toys to have a marketing strategy based extensively on television and advertising, which has been copied widely by other toys. It is estimated that over a billion Barbie dolls have been sold worldwide in over 150 countries, with Mattel claiming that two Barbie dolls are sold every second.

The standard range of Barbie dolls and related accessories are manufactured to approximately 1/6th scale, which is also known as playscale. Barbie products include not only the range of dolls with their clothes and accessories, but also a huge range of Barbie branded goods such as books, fashion items and video games. Barbie has appeared in a series of animated films and made a brief guest appearance in the 1999 film Toy Story 2.

Barbie has become a cultural icon and has been given honors that are rare in the toy world. In 1974 a section of Times Square in New York City was renamed Barbie Boulevard for a week, In 1985 the artist Andy Warhol created a painting of Barbie.

(SOURCE:)

--

Friday, September 4, 2009

ARROYO - declares Sept. 7 and 21 as non-working holidays

President Gloria Macapagal Arroyo on Friday declared September 7 and 21 as non-working holidays.

Malacañang said September 7 will be observed as a “national day of mourning" in honor of Iglesia ni Cristo’s executive minister Eraño Manalo, who passed away last Monday due to cardiopulmonary arrest.

Mrs. Arroyo said flags in government offices will be flown at half-mast for the spiritual leader’s burial.

The declaration of September 21 is in observance of the Muslim holiday of EID AL-FITR, which marks the end of the fasting month of Ramadan.

Both Sept. 7 and 21 are Mondays. - (Aie Balagtas)